SANGAMO THERAPEUTICS, INC. (SGMOQ) Net margin 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) net profit margin by fiscal year — reported net income divided by reported revenue.
-310.8%FY2025 · since FY2016: -369.6% → -310.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -310.8% | -141.4 pp |
| FY2024 | -169.4% | -23.1 pp |
| FY2023 | -146.3% | +26.5 pp |
| FY2022 | -172.8% | -11.7 pp |
| FY2021 | -161.1% | -58.7 pp |
| FY2020 | -102.4% | -9.4 pp |
| FY2019 | -92.9% | -12.0 pp |
| FY2018 | -80.9% | +68.3 pp |
| FY2017 | -149.2% | +220.4 pp |
| FY2016 | -369.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice